13F

MAZE MAZE THERAPEUTICS INC

2026Q1 · CUSIP 578784100 · Sector: Healthcare & Biotech

Lit · Institutions accelerating in
Holders
164
Δ holders QoQ
+21
Breadth percentile
Top 15%
Whale holders
80
Δ whales
+11
Inst. holding value
$1.5B
New positions
49
Closed positions
28
Price momentum (1Q)
-47.8%
Put / Call
5/7

Breadth history (34 quarters)

2025Q2: Δ+7 · h=76 2025Q3: Δ+18 · h=94 2025Q4: Δ+49 · h=143 2026Q1: Δ+21 · h=164 2025Q2: holders=76 2025Q3: holders=94 2025Q4: holders=143 2026Q1: holders=164 -49 -24.5 +0 +24.5 +49 68121173 25Q225Q325Q426Q1 Δ holders (bar) Holders (line)

Past Lit Events & Aftermath 3 lit events

Period Percentile Next-1Q return Next-2Q return
2026Q1 Top 15%
2025Q4 Top 10% -47.8%
2025Q3 Top 19% +34.3% -25.4%

Options Sentiment

Put holders
5
QoQ: +5
Call holders
7
QoQ: +5

See methodology →

Fundamentals

PE (TTM)
EPS (TTM)
$-2.35
EPS YoY
-116.8%
Revenue (TTM)
Revenue YoY
Quarterly Revenue & EPS (4Y)
2025-03-31: EPS -1.15 2025-06-30: EPS -0.77 2025-09-30: EPS -0.66 2025-12-31: EPS -0.47 2026-03-31: EPS -0.45 -1.26 -0.63 0.00 202420252026 EPS

Quarterly figures; EPS split-adjusted, early quarters hidden when not calibrable

As of 2026-03-31 · SEC filings (XBRL)